Healthcare Sector

PFE

Market Tracker

$23.95
-0.91
(-3.66%)
8:00 pm
Next Earnings: (est.) 08/01/23 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
11/21/2025 CALL $25.00 23,291 +7,077 +43.65%
09/19/2025 PUT $24.50 8,183 +2,956 +56.55%
09/12/2025 CALL $25.00 12,707 +2,733 +27.40%
10/03/2025 CALL $26.00 4,262 +2,624 +160.20%
09/19/2025 CALL $25.00 39,347 +2,362 +6.39%
09/18/2026 PUT $22.00 4,173 +1,160 +38.50%
09/19/2025 CALL $25.50 10,118 -263 -2.53%
09/19/2025 CALL $27.00 36,940 -299 -0.80%
09/19/2025 CALL $28.00 16,362 -302 -1.81%
09/19/2025 CALL $24.00 21,250 -505 -2.32%
09/19/2025 CALL $26.00 38,689 -545 -1.39%
09/12/2025 PUT $26.00 24,909 -2,182 -8.05%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.02% 170.64M 6.14B
Vanguard 500 Index Fund 2.30% 129.76M 4.67B
Washington Mutual Investors Fund 1.42% 80.41M 2.89B
Fidelity 500 Index Fund 1.09% 61.54M 2.21B
SPDR S&P 500 ETF Trust 1.08% 60.77M 2.19B
American Balanced Fund 1.00% 56.61M 2.04B
Income Fund of America Inc 0.93% 52.68M 1.9B
iShares Core S&P 500 ETF 0.89% 50.1M 1.8B
Vanguard Index-Value Index Fund 0.86% 48.51M 1.75B
Vanguard Specialized-Health Care Fund 0.86% 48.32M 1.74B

PFE News

  • Why BioNTech Stock Sank by More Than 7% Today

    09/12 06:19 pm

    The Motley Fool

    Read more
  • Questex’s Fierce Pharma Announces the 2025 Fierce Pharma Marketing Awards Winners

    09/10 11:30 pm

    GlobeNewswire Inc.

    Read more
  • FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects

    09/10 01:21 pm

    Benzinga

    Read more
  • HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program

    09/09 08:00 am

    GlobeNewswire Inc.

    Read more
  • The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now

    09/09 06:05 am

    The Motley Fool

    Read more
  • Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

    09/08 02:13 pm

    Benzinga

    Read more
  • Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.

    09/07 11:14 am

    The Motley Fool

    Read more
  • Is Pfizer a Millionaire Maker?

    09/07 09:30 am

    The Motley Fool

    Read more
  • Down 34%, Should You Buy the Dip on Viking Therapeutics?

    09/05 04:10 am

    The Motley Fool

    Read more
  • Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

    09/04 11:00 am

    GlobeNewswire Inc.

    Read more
  • Monoclonal Antibodies Therapeutics Market Size Projected to Reach USD 1,057.91 Billion by 2034

    09/04 11:00 am

    GlobeNewswire Inc.

    Read more
  • Salesforce Posts 10% Revenue Gain in Q2

    09/04 09:05 am

    The Motley Fool

    Read more
  • PDE4B Inhibitor Market Poised for Strong Growth by 2034 | DelveInsight

    09/03 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Stomach Cancer Treatment Market Review 2020-2024 and Forecast 2025-2030 - Novel Therapies, Increasing Demand for Affordable Treatments, and Favorable Reimbursement Scenario Position the Market for Strong Growth

    09/03 04:49 am

    GlobeNewswire Inc.

    Read more
  • Healthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry

    09/02 09:37 am

    Investing.com

    Read more
  • 3 High-Yield Dividend Stocks You Can Buy in September and Hold Forever

    09/02 03:21 am

    The Motley Fool

    Read more
  • Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034

    09/01 10:00 am

    GlobeNewswire Inc.

    Read more
  • Epinephrine Market to Size to Reach USD 5.74 Billion by 2032 as Demand for Emergency Allergy Treatments Surges – SNS Insider

    09/01 09:00 am

    GlobeNewswire Inc.

    Read more
  • Healthcare Is Sickly but These Dividend Yields up to 7% May Still Have a Pulse

    08/29 05:14 am

    Investing.com

    Read more
  • Global Pharmaceuticals Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight

    08/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

    08/27 12:50 pm

    GlobeNewswire Inc.

    Read more
  • Human Growth Hormone Market to Hit USD 18.25 Billion by 2032, Driven by Expanding Therapeutic Applications and Biotech Advances – SNS Insider

    08/27 10:00 am

    GlobeNewswire Inc.

    Read more
  • Binge Eating Disorders Global Market Research Report 2025-2035 Featuring Eli Lilly, Amneal, Takeda, Tryp Therapeutics, Tonix, Sumitomo, VIVUS, Novartis, and Pfize

    08/27 08:00 am

    GlobeNewswire Inc.

    Read more
  • Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

    08/27 04:59 am

    GlobeNewswire Inc.

    Read more
  • Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

    08/27 04:50 am

    GlobeNewswire Inc.

    Read more
  • Viking Therapeutics: What's Next?

    08/26 06:15 am

    The Motley Fool

    Read more
  • Global Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsight

    08/21 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates

    08/20 07:57 pm

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing

    08/20 10:00 am

    GlobeNewswire Inc.

    Read more
  • Ligand to Participate in September Investor Conferences

    08/19 04:00 pm

    GlobeNewswire Inc.

    Read more
  • New Obesity Drugs May See Premium Pricing Undermined By Underwhelming Data

    08/19 02:28 pm

    Benzinga

    Read more
  • PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight

    08/18 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Top Dividend Stocks to Buy on the Dip

    08/16 09:07 am

    The Motley Fool

    Read more
  • 3 Long-Term Dividend Buys You Can Get for Under $50

    08/15 10:37 am

    Investing.com

    Read more
  • After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?

    08/15 07:15 am

    The Motley Fool

    Read more
  • Ligand Announces Closing of Convertible Senior Notes Offering

    08/14 04:00 pm

    GlobeNewswire Inc.

    Read more
  • CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

    08/12 01:41 pm

    Benzinga

    Read more
  • Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

    08/12 10:46 am

    Benzinga

    Read more
  • Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering

    08/11 11:46 pm

    GlobeNewswire Inc.

    Read more
  • If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today

    08/11 09:16 pm

    The Motley Fool

    Read more
  • Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?

    08/11 08:15 pm

    The Motley Fool

    Read more
  • Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030

    08/11 07:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Beaten-Down Stocks to Buy and Hold

    08/10 09:15 am

    The Motley Fool

    Read more
  • Meet the 7.3% Yield Dividend Stock That Could Soar in 2026

    08/10 06:05 am

    The Motley Fool

    Read more
  • Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025

    08/08 02:45 am

    GlobeNewswire Inc.

    Read more
  • Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight

    08/07 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025

    08/07 08:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: